C2N Diagnostics

Saint Louis, MO · Founded 2007 · Privately Held (backing)

Provider of specialty diagnostic testing services intended to offer novel diagnostics for Alzheimer's disease. C2N Diagnostics is based in Saint Louis, MO and was founded in 2007. It has raised $95 million across 2 recorded rounds; the latest was a $10 million early-stage round in May 2025.

Last price · $/share
—
Implied valuation
—
Total raised
$95.0M
Last round
Early Stage VC
May 2025

Who backs C2N Diagnostics?

9 investors
InvestorType
Samsung Venture InvestmentOther
Washington University in St. LouisOther
GHR FoundationOther
Alzheimers Drug Discovery Foundation—
Diagnostics Accelerator—
Eisai—
Michael J. Fox Foundation—
Samsung C&T—
The National Institute on Aging (NIA)—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

C2N Diagnostics investors

9 investors are on record for C2N Diagnostics, including Samsung Venture Investment, Washington University in St. Louis, GHR Foundation and Alzheimers Drug Discovery Foundation. The early-stage round in May 2025 drew 1 investor.

Free account
More of C2N Diagnostics with a free account
  • ·Watch C2N Diagnostics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like C2N Diagnostics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View